CoChat

A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

Onken, Jane E., Bregman, David B., Harrington, Robert A., Morris, David, Acs, Peter, Akright, Bruce, Barish, Charles, Bhaskar, Birbal S., Smith‐Nguyen, Gioi N., Butcher, Angelia, Koch, Todd A., Goodnough, Lawrence T. · 2014 · Transfusion
Cited by 154

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: Many patients receiving oral iron for iron deficiency anemia ( IDA ) cannot tolerate or fail to respond to therapy, and existing intravenous ( IV ) iron formulations often require repeated administrations. Ferric carboxymaltose ( FCM ), a nondextran IV formulation, permits larger single doses. Study Design and Methods: We evaluated FCM versus oral iron in IDA patients. After 14 days of oral iron, 507 participants responding inadequately to oral iron (hemoglobin [Hb] increase <1 g/ dL ; Cohort 1) were assigned to Group A (two doses of FCM , 750 mg, 1 week apart) or Group B (oral iron, 325 mg, 3 × day for 14 additional days). Also, 504 subjects not appropriate for oral iron (Cohort 2) were assigned to Group C ( FCM as above) or Group D (standard‐of‐care IV iron). The primary efficacy endpoint was change to highest observed Hb from baseline to Day 35. The composite safety endpoint included all‐cause mortality, nonfatal myocardial infarction, nonfatal stroke, unstable angina, heart failure, arrhythmias, and hyper‐ or hypotensive events. Results: Mean (± standard deviation [ SD ]) Hb increase was significantly greater in Group A– FCM than Group B–oral iron: 1.57 (±1.19) g/ dL versus 0.80 (±0.80) g/ dL (p = 0.001). Post hoc comparison of Group C – FCM and Group D –IV standard of care also demonstrated significant mean (± SD ) increase in Hb from baseline to highest value by Day 35 in Group C versus Group D: 2.90 (±1.64) g/ dL versus 2.16 (±1.25) g/dL (p = 0.001). Safety endpoints occurred in 17 of 499 (3.4%) participants receiving FCM versus 16 of 498 (3.2%) in comparator groups. Conclusion: Two 750‐mg FCM infusions are safe and superior to oral iron in increasing Hb levels in IDA patients with inadequate oral iron response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/trf.12289

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Onken, J. E., Bregman, D. B., Harrington, R. A., Morris, D., Acs, P., Akright, B., Barish, C., Bhaskar, B. S., Smith‐Nguyen, G. N., Butcher, A., Koch, T. A., & Goodnough, L. T.
Venue
Transfusion
Publisher
Wiley
Published
2013-06-17
Volume
54
Issue
2
Pages
306-315
ISSN
  • 0041-1132 (ISSN-L)
  • 1537-2995
OpenAlex
W2097503522
Cited by
154
References
4
FWCI
6.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.